Remedent Past Earnings Performance
Past criteria checks 0/6
Remedent's earnings have been declining at an average annual rate of -330.6%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 88.5% per year.
Key information
-330.6%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -88.5% |
| Return on equity | -10.5% |
| Net Margin | -659.6% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Remedent makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 0 | 0 | 1 | 0 |
| 31 Mar 22 | 0 | 0 | 0 | 0 |
| 31 Mar 21 | 0 | 0 | 0 | 0 |
| 31 Dec 20 | 1 | 0 | 1 | 0 |
| 30 Sep 20 | 1 | 0 | 1 | 0 |
| 30 Jun 20 | 1 | -1 | 1 | 0 |
| 31 Mar 20 | 0 | 0 | 1 | 0 |
| 31 Dec 19 | 1 | 2 | 1 | 0 |
| 30 Sep 19 | 1 | 2 | 1 | 0 |
| 30 Jun 19 | 1 | 2 | 1 | 0 |
| 31 Mar 19 | 1 | 2 | 2 | 0 |
| 31 Dec 18 | 1 | -1 | 2 | 0 |
| 30 Sep 18 | 2 | 0 | 2 | 0 |
| 30 Jun 18 | 2 | 0 | 2 | 0 |
| 31 Mar 18 | 2 | 0 | 2 | 0 |
| 31 Dec 17 | 2 | 1 | 2 | 0 |
| 30 Sep 17 | 2 | 1 | 2 | 0 |
| 30 Jun 17 | 2 | 1 | 2 | 0 |
| 31 Mar 17 | 2 | 1 | 2 | 0 |
| 31 Dec 16 | 2 | 0 | 2 | 0 |
| 30 Sep 16 | 2 | 0 | 2 | 0 |
| 30 Jun 16 | 2 | 0 | 2 | 0 |
| 31 Mar 16 | 2 | 0 | 2 | 0 |
| 31 Dec 15 | 3 | 0 | 2 | 0 |
| 30 Sep 15 | 3 | 0 | 1 | 0 |
| 30 Jun 15 | 3 | 0 | 2 | 0 |
| 31 Mar 15 | 3 | 0 | 2 | 0 |
| 31 Dec 14 | 2 | 0 | 2 | 0 |
| 30 Sep 14 | 2 | 0 | 2 | 0 |
| 30 Jun 14 | 2 | 0 | 2 | 0 |
| 31 Mar 14 | 2 | 0 | 1 | 0 |
| 31 Dec 13 | 3 | 0 | 2 | 0 |
| 30 Sep 13 | 3 | 0 | 2 | 0 |
| 30 Jun 13 | 2 | 0 | 2 | 0 |
Quality Earnings: REMI is currently unprofitable.
Growing Profit Margin: REMI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if REMI's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare REMI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: REMI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: REMI has a negative Return on Equity (-10.48%), as it is currently unprofitable.